Drug Sponsors

Astrazeneca to close India R&D site

Friday, January 31, 2014 12:49 PM

AstraZeneca plans to close its Avishkar R&D site in Bangalore later this year, part of the company's broader global business strategy to simplify its R&D footprint and focus resources on three core therapy areas: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity.

More... »


Janssen R&D launches novel trial data sharing agreement with Yale School of Medicine

Thursday, January 30, 2014 10:49 AM

Johnson & Johnson subsidiary Janssen Research and Development has entered into a novel agreement with Yale School of Medicine's Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. 

More... »


Medigene acquires Trianta Immunotherapies

Wednesday, January 29, 2014 01:16 PM

Medigene, a biotechnology company headquartered in Martinsried, Germany, has acquired Munich-based Trianta Immunotherapies, recently spun out from the Munich Helmholtz Center.

More... »

Midwest healthcare companies raise $758 million in 2013

Wednesday, January 29, 2014 12:55 PM

Midwest healthcare companies attracted $758 million in new investments across 217 companies in 2013, according to the BioEnterprise Midwest Healthcare Venture Investment Report. As with the nationwide trend, Midwest investment decreased from 2012. Ohio ($296 million) and Minnesota ($228 million) led Midwestern states in attracting investment dollars.

More... »

Sony, M3, Illumina to launch new genome company in Japan

Monday, January 27, 2014 01:24 PM

Sony, M3 and Illumina have formed a collaboration to launch a "genome information platform" in Japan. Sony and M3 will establish a new company, with Illumina as a minority investor, by the end of February.

More... »

Janssen forms new group targeting unmet global health needs

Friday, January 24, 2014 11:47 AM

Janssen, the pharmaceutical companies of Johnson & Johnson, has formed Janssen Global Public Health (Janssen GPH), a new group unifying Janssen's commitment to research, develop and deliver transformational medicines to address the world's greatest unmet public health needs.

More... »

McKesson acquires Celesio

Friday, January 24, 2014 11:44 AM

McKesson, a North American healthcare services and information technology company, has reached an agreement with Franz Haniel to acquire its entire holding of Celesio shares for $32.24 per share. In a separate and subsequent agreement, McKesson announced the acquisition of Celesio convertible bonds from Elliott. These agreements are not subject to any closing conditions and the transactions are expected to close within 10 business days. After the close of the agreements, McKesson will own more than 75% of Celesio shares on a fully diluted basis.

More... »

NuPathe terminates agreement with Endo, to be acquired by Teva

Wednesday, January 22, 2014 12:28 PM

NuPathe, a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system, has terminated its agreement and plan to merge with Endo Health Solutions, and its board has withdrawn its recommendation that stockholders accept Endo's offer to acquire all outstanding shares of NuPathe common stock.

More... »

Aurobindo acquires commercial operations in seven countries from Actavis

Monday, January 20, 2014 11:59 AM

Aurobindo Pharma, a Hyderabad, India-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, has signed a binding offer to acquire commercial operations in seven Western European countries from Actavis, a Dublin, Ireland-based global, integrated specialty pharmaceutical company. Closing of the transaction is conditional on certain antitrust approvals and completion of employee consultation processes.

More... »

Carlyle Group makes binding offer to acquire J&J’s Ortho-Clinical Diagnostics

Friday, January 17, 2014 11:34 AM

Johnson & Johnson has received a binding offer from the Carlyle Group to acquire its Ortho-Clinical Diagnostics business for $4.15 billion. Ortho-Clinical Diagnostics delivers in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.

More... »

CenterWatch
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs